Natural selection opportunities tied to cancer rates

Print Friendly, PDF & Email


Cancer patient receiving chemotherapy
Photo by Rhoda Baer
Countries with the lowest opportunities for natural selection have higher cancer rates than countries with the highest opportunities for natural selection, according to a study published in Evolutionary Applications. Researchers said this is because modern medicine is enabling people to survive cancers, and their genetic... [Read Article]
Print Friendly, PDF & Email

Drug receives breakthrough designation for HL

Print Friendly, PDF & Email


Brentuximab vedotin
Photo from Business Wire
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to brentuximab vedotin (BV, Adcetris) for use in combination with chemotherapy as frontline treatment of advanced classical Hodgkin lymphoma (HL). Seattle Genetics and Takeda plan to submit a supplemental biologics license application seeking approval for... [Read Article]
Print Friendly, PDF & Email